This brand name is authorized in Canada, New Zealand, United Kingdom
The drug ANTIZOL contains one active pharmaceutical ingredient (API):
1
Fomepizole
UNII 83LCM6L2BY - FOMEPIZOLE
|
Fomepizole is a competitive inhibitor of alcohol dehydrogenase. Alcohol dehydrogenase catalyzes the oxidation of ethanol to acetaldehyde and the initial steps in the metabolism of ethylene glycol and methanol to their toxic metabolites. Fomepizole is indicated as an antidote for ethylene glycol (such as antifreeze) or methanol poisoning (such as windshield washer fluid), or for use in suspected ethylene glycol or methanol ingestion, either alone or in combination with hemodialysis. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
ANTIZOL Solution for injection | Health Products and Food Branch (CA) | MPI, CA: SPM |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
V03AB34 | Fomepizole | V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AB Antidotes |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: CA | Health Products and Food Branch | Identifier(s): 02242980 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 199327 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 17615 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.